NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lasertec Corporation (“Lasertec” or the “Company”) (OTC: LSRCF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The investigation concerns whether Lasertec and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On June 5, 2024, Scorpion Capital (“Scorpion”) published an investigative report on Lasertec. Scorpion accused Lasertec of concocting a textbook accounting scheme, fraudulently inflating revenue, margins, and earnings. Scorpion also predicts that Lasertec will incur a significant impairment charge that could erase most of the Company’s earnings since the launch of its flagship ACTIS extreme ultraviolet inspection machine.
On this news, Lasertec’s stock price fell $27.00 per share, or 10.33%, to close at $234.50 per share on June 5, 2024.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980
